A previous study has reported that the efficacy of the IFN-α + 5-FU regimen was similar to that of best salvage therapy (low-dose cisplatin + 5-FU or cisplatin alone intraarterial infusion chemotherapy) in advanced HCC patients with a high degree of vascular invasion 33. This evidence concerns the gene IFNA1 and hepatocellular carcinoma.